Kao I-Ting, Yao Chao-Ling, Kong Zwe-Ling, Wu Mei-Ling, Chuang Tzu-Lin, Hwang Shiaw-Min
Bioresource Collection and Research Center, Food Industry Research and Development Institute, Hsinchu, Taiwan.
Stem Cells Dev. 2007 Dec;16(6):1043-51. doi: 10.1089/scd.2007.0033.
Natural killer (NK) cells are important effectors of the innate immune system, which exhibits cytolytic activity against infectious agents and tumor cells. NK cells are derived from CD34(+) hematopoietic stem cells (HSCs). Human umbilical cord blood (UCB) has been recognized as a rich source of HSCs. Previously, we have reported an optimized serum-free medium for ex vivo expansion of CD34(+) cells from UCB. In this study, the serum-free, expanded CD34(+) cells were tested to differentiate into NK cells and their induction kinetics. After 5 weeks of induction, the induced NK cells were characterized by analysis of surface antigens, IFN-gamma secretion, and cytotoxicity against K562 cells. The results indicated that NK cells derived from the serum-free, expanded CD34(+) cells exhibited both characteristics and functions of NK cells. Furthermore, the serum-free, expanded CD34(+) cells showed a significantly higher NK cell differentiation potential than freshly isolated CD34(+) cells. NK cells induced from serum-free, expanded CD34(+) cells showed a higher concentration of IFN-gamma secretion and ability of cytotoxicity than those from freshly isolated CD34(+) cells. Therefore, ex vivo-expanded CD34(+) cells in optimized serum-free medium could differentiate into NK cells and provided a promising cell source for immunotherapeutic approaches.
自然杀伤(NK)细胞是先天性免疫系统的重要效应细胞,对感染因子和肿瘤细胞具有细胞溶解活性。NK细胞来源于CD34(+)造血干细胞(HSCs)。人脐带血(UCB)已被公认为是HSCs的丰富来源。此前,我们报道了一种用于从UCB中体外扩增CD34(+)细胞的优化无血清培养基。在本研究中,对无血清扩增的CD34(+)细胞进行了分化为NK细胞及其诱导动力学的测试。诱导5周后,通过分析表面抗原、IFN-γ分泌以及对K562细胞的细胞毒性对诱导的NK细胞进行表征。结果表明,无血清扩增的CD34(+)细胞来源的NK细胞表现出NK细胞的特征和功能。此外,无血清扩增的CD34(+)细胞显示出比新鲜分离的CD34(+)细胞显著更高的NK细胞分化潜能。无血清扩增的CD34(+)细胞诱导产生的NK细胞比新鲜分离的CD34(+)细胞诱导产生的NK细胞表现出更高的IFN-γ分泌浓度和细胞毒性能力。因此,在优化的无血清培养基中体外扩增的CD34(+)细胞可分化为NK细胞,并为免疫治疗方法提供了一种有前景的细胞来源。